User name

Don't have a user name yet?
Register here.


With EUR 56m investment, Krka doubles R&D capacities

Novo Mesto, 1 October - Krka, the Novo Mesto-seated pharmaceuticals group, has launched a new research and development centre to nearly double its R&D, and control and analysis capacities.

Novo Mesto
The management of pharmaceuticals company Krka presents a new R&D centre which almost doubles its R&D and control and analysis capacities.
Photo: Rasto Božič/STA

Novo Mesto
Krka director general Jože Colarič.
Photo: Rasto Božič/STA

The rest of this news item is available to subscribers.
The news item consists of 1.538 characters (without spaces) or 304 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2019